125 related articles for article (PubMed ID: 3865500)
1. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
[TBL] [Abstract][Full Text] [Related]
3. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
4. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
[TBL] [Abstract][Full Text] [Related]
5. Depot perphenazine decanoate and enanthate for schizophrenia.
Quraishi S; David A
Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
[TBL] [Abstract][Full Text] [Related]
6. A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients.
Dencker SJ; Giös I; Mårtensson E; Nordén T; Nyberg G; Persson R; Roman G; Stockman O; Svärd KO
Psychopharmacology (Berl); 1994 Feb; 114(1):24-30. PubMed ID: 7846204
[TBL] [Abstract][Full Text] [Related]
7. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
[TBL] [Abstract][Full Text] [Related]
8. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
[TBL] [Abstract][Full Text] [Related]
9. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Ahlfors UG; Dencker SJ; Gravem A; Remvig J
Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
[TBL] [Abstract][Full Text] [Related]
10. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men.
Lindholm H; Gullberg B; Ohman A; Sedvall G
Psychopharmacology (Berl); 1978 Apr; 57(1):1-4. PubMed ID: 96459
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks.
Larsen NE; Hansen LB
Ther Drug Monit; 1989 Nov; 11(6):642-6. PubMed ID: 2595744
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Knudsen P
Acta Psychiatr Scand Suppl; 1985; 322():51-75. PubMed ID: 2866666
[TBL] [Abstract][Full Text] [Related]
13. Abscesses following prolonged intramuscular administration of perphenazine enantate.
Starmark JE; Forsman A; Wahlström
Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine enanthate in sesame oil, a depot preparation.
Rasmussen OS
Acta Psychiatr Scand; 1970; 46(3):311-8. PubMed ID: 5490593
[No Abstract] [Full Text] [Related]
15. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Eufe R; Wegener G
Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
[No Abstract] [Full Text] [Related]
16. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic profile of perphenazine enanthate].
Viala A
Encephale; 1976; 2(3):273-82. PubMed ID: 991807
[TBL] [Abstract][Full Text] [Related]
18. The relationship between perphenazine plasma levels and clinical response in acute schizophrenia.
Omérov M; Wistedt B; Bolvig-Hansen L; Larsen NE
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):159-66. PubMed ID: 2664884
[TBL] [Abstract][Full Text] [Related]
19. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.
Talvik M; Nordström AL; Larsen NE; Jucaite A; Cervenka S; Halldin C; Farde L
Psychopharmacology (Berl); 2004 Sep; 175(2):148-53. PubMed ID: 15007534
[TBL] [Abstract][Full Text] [Related]
20. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
